Johnathan Grunfeld M.D. graduated from the Tel-Aviv University (Sackler) School of Medicine in 1996 and was certified as a neurologist in Israel in 2002. In 2004 he completed a two-year clinical fellowship in Neuro-Oncology in the MD Anderson Cancer Centre, Houston, Texas, USA. Until 2019 he was the Head of Palliative Care Services at the Shamir Medical Centre, Israel and since 2019 has been the Chief Medical Officer at MGC Pharma. Johnathan Grunfeld M.D. has accrued direct clinical experience, using cannabis for medical indications, with 5,000 patients. He is supervising a project in the next round.